Rational drug therapy of the hyperlipoproteinemias, Part II.
Blum
C B
CB
Levy
R I
RI
D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003084:Colestipol / Q000627:therapeutic use; D003918:Dextrothyroxine / Q000627:therapeutic use; D005260:Female; D005395:Fish Oils / Q000627:therapeutic use; D015248:Gemfibrozil; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006951:Hyperlipoproteinemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D009355:Neomycin / Q000627:therapeutic use; D009525:Niacin / Q000627:therapeutic use; D010421:Pentanoic Acids / Q000627:therapeutic use; D011341:Probucol / Q000627:therapeutic use
D005395:Fish Oils; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D010421:Pentanoic Acids; D002792:Cholestyramine Resin; D009525:Niacin; D003918:Dextrothyroxine; D002994:Clofibrate; D009355:Neomycin; D003084:Colestipol; D011341:Probucol; D015248:Gemfibrozil